leflunomide
CONCLUSIONS: The biochemical mechanisms       underlying the therapeutic efficacy of low-dose methotrexate and leflunomide in       the treatment of RA are quite different.
CONCLUSIONS: The biochemical mechanisms       underlying the therapeutic efficacy of low-dose methotrexate and  @SUBJECT$  in       the  @PREDICAT$  of  @OBJECT$  are quite different.